Sub Banner Image

Novo Backed by Key Danish Investor as Drugmaker Seeks Revival

Markets

Sara Sjolin, Christian Wienberg

·

September 2, 2025

·

Bloomberg

Denmark’s largest pension fund has boosted its stake in Novo Nordisk A/S this year, betting the obesity drugmaker will outpace rivals beyond the US market where its struggles have led to two profit warnings.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.